Heptares Therapeutics
E108401
Heptares Therapeutics is a biopharmaceutical company specializing in the discovery and development of medicines targeting G protein-coupled receptors (GPCRs) using its proprietary structure-based drug design technologies.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Heptares | 1 |
| Heptares Therapeutics canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T916702 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Heptares Therapeutics Context triple: [Granta Park, hasTenant, Heptares Therapeutics]
-
A.
Optica
Optica is a leading scientific society dedicated to advancing the study and application of optics and photonics worldwide.
-
B.
Microsystems Technology Laboratories
Microsystems Technology Laboratories is a leading MIT research facility focused on micro- and nano-scale engineering, including microelectronics, MEMS, and related technologies.
-
C.
Elxsi
Elxsi was a computer company known for developing high-performance minicomputers and multiprocessor systems in the late 20th century.
-
D.
Mobileye
Mobileye is an Israeli technology company specializing in advanced driver-assistance systems and autonomous driving solutions, known for its computer vision and mapping technologies used by major automakers worldwide.
-
E.
Boston Scientific
Boston Scientific is a global medical technology company known for developing and manufacturing minimally invasive medical devices, particularly in cardiology and other interventional specialties.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Heptares Therapeutics Target entity description: Heptares Therapeutics is a biopharmaceutical company specializing in the discovery and development of medicines targeting G protein-coupled receptors (GPCRs) using its proprietary structure-based drug design technologies.
-
A.
Optica
Optica is a leading scientific society dedicated to advancing the study and application of optics and photonics worldwide.
-
B.
Microsystems Technology Laboratories
Microsystems Technology Laboratories is a leading MIT research facility focused on micro- and nano-scale engineering, including microelectronics, MEMS, and related technologies.
-
C.
Elxsi
Elxsi was a computer company known for developing high-performance minicomputers and multiprocessor systems in the late 20th century.
-
D.
Mobileye
Mobileye is an Israeli technology company specializing in advanced driver-assistance systems and autonomous driving solutions, known for its computer vision and mapping technologies used by major automakers worldwide.
-
E.
Boston Scientific
Boston Scientific is a global medical technology company known for developing and manufacturing minimally invasive medical devices, particularly in cardiology and other interventional specialties.
- F. None of above. chosen
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
drug discovery company ⓘ privately held company ⓘ subsidiary ⓘ |
| abbreviation |
Heptares Therapeutics
self-linksurface differs
ⓘ
surface form:
Heptares
|
| collaboratesWith |
Allergan
ⓘ
AstraZeneca ⓘ Janssen Biotech ⓘ Kymab ⓘ Pfizer ⓘ Takeda Pharmaceutical Company ⓘ Teva Pharmaceutical Industries ⓘ |
| country | United Kingdom ⓘ |
| develops |
biologics
ⓘ
small-molecule drugs ⓘ |
| field |
GPCR drug discovery
ⓘ
structure-based drug design ⓘ |
| focusesOnTarget | G protein-coupled receptors ⓘ |
| foundedBy |
Christopher Tate
ⓘ
David Marshall ⓘ Fiona Marshall ⓘ
surface form:
Fiona H. Marshall
Fiona Marshall ⓘ Florence Ni ⓘ Gebhard Schertler ⓘ Grahame Marshall ⓘ Malcolm Weir ⓘ Michel Bouvier ⓘ Miles Congreve ⓘ Richard Henderson ⓘ |
| foundedIn | 2007 ⓘ |
| hasKeyPerson |
Fiona Marshall
ⓘ
surface form:
Fiona H. Marshall
Malcolm Weir ⓘ Shinichi Tamura ⓘ |
| hasParentCompanyStockExchangeListing | Tokyo Stock Exchange (via Sosei Group Corporation) ⓘ |
| hasResearchFocus |
central nervous system disorders
ⓘ
gastrointestinal diseases ⓘ immunology ⓘ metabolic diseases ⓘ neurology ⓘ oncology ⓘ |
| headquartersLocation | Hertfordshire, United Kingdom ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| locationCountry | United Kingdom ⓘ |
| parentOrganization | Sosei Group Corporation ⓘ |
| specializesIn |
development of medicines targeting G protein-coupled receptors
ⓘ
discovery of medicines targeting G protein-coupled receptors ⓘ structure-based drug design ⓘ |
| technologyBrand | StaR technology ⓘ |
| usesTechnology | proprietary structure-based drug design technologies ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Heptares Therapeutics Description of subject: Heptares Therapeutics is a biopharmaceutical company specializing in the discovery and development of medicines targeting G protein-coupled receptors (GPCRs) using its proprietary structure-based drug design technologies.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Heptares